An observational study of NeuVax in patients with gastric adenocarcinoma

Trial Profile

An observational study of NeuVax in patients with gastric adenocarcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2016

At a glance

  • Drugs Nelipepimut-S (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Dr Reddys Laboratories
  • Most Recent Events

    • 14 Mar 2016 New trial record
    • 10 Mar 2016 Results from this trial were presented at the ASCO 2016 Gastrointestinal Cancers Symposium, according to a Galena Biopharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top